271 related articles for article (PubMed ID: 35111402)
1. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
PeerJ; 2022; 10():e12768. PubMed ID: 35111402
[TBL] [Abstract][Full Text] [Related]
2. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
[TBL] [Abstract][Full Text] [Related]
4. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
Yin X; Wu Q; Hao Z; Chen L
Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
[TBL] [Abstract][Full Text] [Related]
7. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
9. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
[TBL] [Abstract][Full Text] [Related]
10. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
[TBL] [Abstract][Full Text] [Related]
11. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
[TBL] [Abstract][Full Text] [Related]
12. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
13. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
Front Genet; 2020; 11():253. PubMed ID: 32296458
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
Yang A; Wang X; Hu Y; Shang C; Hong Y
Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate biomarkers for GBM based on WGCNA.
Sun Q; Wang Z; Xiu H; He N; Liu M; Yin L
Sci Rep; 2024 May; 14(1):10692. PubMed ID: 38724609
[TBL] [Abstract][Full Text] [Related]
18. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
Güven E; Afzal M; Kazmi I
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma.
Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y
Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808
[TBL] [Abstract][Full Text] [Related]
20. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]